Volatile:ListMol

Searching titles with LBF20 in the default namespace.

Showing below 320 results of search LBF20.

  1. LBF20000AM01:   N-Eicosanoylethanolamine  
  2. LBF20000AM02:   N-Eicosanoyl-(2'-fluoroethyl)amine  
  3. LBF20000BC01:   (+)-18-Methyleicosanoic acid  
  4. LBF20000HO01:   2-Hydroxyeicosanoic acid  
  5. LBF20000HO02:   3-Hydroxyeicosanoic acid  
  6. LBF20000HO03:   20-Hydroxyeicosanoic acid  
  7. LBF20000HO04:   11,12-Dihydroxyarachidic acid  
  8. LBF20000PG01:   13,14-dihydro Prostaglandin E_1  
  9. LBF20000PG02:   13,14-dihydro-15-keto Prostaglandin E_1  
  10. LBF20000SC01:   Arachidic acid
  11. LBF20106SC01:   14Z-Eicosenoic acid  
  12. LBF20107PG01:   Prostaglandin E_1  (8R,11R,12R,13E,15S) -11,15-Dihydroxy-9-oxo-13-prostenoic acid  7- [3R- Hydroxy- 2R- (3S -hydroxy-1(E) -octenyl) -5-oxocyclopentan-1R-yl] -heptanoic acid  
  13. LBF20107PG02:   6-keto Prostaglandin E_1  7- [3R- Hydroxy- 2R- (3S -hydroxy-1-(E) -octenyl) -5-oxocyclopentan-1R-yl] -oxoheptanoic acid  
  14. LBF20107PG03:   Prostaglandin F1α  (8R,9S,11R,13E,15S) -9,11,15-Trihydroxyprost-13-enoic acid  
  15. LBF20107PG04:   15-keto Prostaglandin E_1  9,15-Dioxo-11α-hydroxy-prost-13(E)-en-1-oic acid  
  16. LBF20107PG05:   19R-hydroxy Prostaglandin E_1  9-Oxo- (11α,15S,19R) -trihydroxy-prost-13(E)-en-1-oic acid  
  17. LBF20107PG06:   15-keto Prostaglandin F1α  (9α,11α) -Dihydroxy-15-oxo-prost-13(E)-en-1-oic acid  
  18. LBF20107PG07:   19R -hydroxy Prostaglandin F1α  (9α,11α,15S,19R) -Tetrahydroxy-prost-13(E)-en-1-oic acid
  19. LBF20107PG08:   Prostaglandin D_1  (9α,15S) -Dihydroxy-11-oxo-prost-13(E)-en-1-oic acid  
  20. LBF20107PG09:   Prostaglandin E1 alcohol  (1,11α,15S) -Trihydroxy-prost-13(E)-en-9-one  
  21. LBF20107PG10:   11-deoxy Prostaglandin E_1  9-Oxo-15S-hydroxy-prosto-13(E)-en-1-oic acid  
  22. LBF20107PG11:   15R-Prostaglandin E_1  9-Oxo- (11α,15R) -dihydroxy-prost-13(E)-en-1-oic acid  
  23. LBF20107PG12:   11-deoxy Prostaglandin F1α  (9α,15S) -Dihydroxy-prost-13(E)-en-1-oic acid  
  24. LBF20107PG13:   Prostaglandin F1β  (9β,11α,15S) -Trihydroxy-prost-13(E)-en-1-oic acid  
  25. LBF20107PG14:   11-deoxy Prostaglandin F1β  (9β,15S) -Dihydroxy-prost-13(E)-en-1-oic acid  
  26. LBF20107PG15:   11β-Prostaglandin E_1  9-Oxo- (11β,15S) -dihydroxy-prost-13(E)-en-1-oic acid  
  27. LBF20107PG17:   11-deoxy Prostaglandin F1β  (9β,15S) -Dihydroxyprost-13(E)-en-1-oic acid  
  28. LBF20107PG18:   6-keto Prostaglandin F_1α  7- [ 3 (R) ,5 (S) -Dihydroxy-2 (R) - (3 (S) -hydroxy-1 (E) -octenyl) cyclopentan-1 (R) -yl ] -6-oxoheptanoic acid   
  29. LBF20107PG19:   8-iso Prostaglandin E_1  9-Oxo-(11α,15S) -dihydroxy- (8β) -prost-13E-en-1-oic acid  
  30. LBF20107PG20:   6α-Prostaglandin I_1  (6R,9α) -Epoxy- (11α,15S) -dihydroxy-prost-13(E)-en-1-oic acid  
  31. LBF20107PG21:   6β-Prostaglandin I_1  (6S,9α) -Epoxy- (11α,15S) -dihydroxy-prost-13(E)-en-1-oic acid  
  32. LBF20107PG22:   15S-15-methyl Prostaglandin E_1  9-Oxo- (11α,15S) -dihydroxy-15-methylprost-13(E)-en-1-oic acid  
  33. LBF20107PG23:   Prostaglandin H_1  (9α,11α) -Epidioxy-15S-hydroxy-prost-13(E)-en-1-oic acid  
  34. LBF20107PG24:   16,16-dimethyl Prostaglandin E_1  9-Oxo- (11α,15R) -dihydroxy-16,16-dimethyl-prost-13(E)-en-1-oic acid  
  35. LBF20107PG25:   6,15-Dioxo- (9α,11α) -dihydroxy-prostan-1-oic acid  6,15-Diketo-13,14-dihydro Prostaglandin F1α  
  36. LBF20109HO01:   Lesquerolic acid  14-Hydroxy-(Z)-11-eicosenoic acid
  37. LBF20109SC01:   11Z-Eicosenoic acid  cis-Gondoic acid&
  38. LBF20109SC02:   11E-Eicosenoic acid  trans-Gondoic acid  
  39. LBF20111SC01:   9Z-Eicosenoic acid  cis-Gadoleic acid  
  40. LBF20115PG01:   13,14-dihydro-15-keto Prostaglandin D_2  9α-Hydroxy-11,15-dioxo-prost-5(Z)-en-1-oic acid  
  41. LBF20115PG02:   13,14-dihydro-15-keto Prostaglandin E_2  9,15-Dioxo-11α-hydroxy-prost-5(Z)-en-1-oic acid  
  42. LBF20115PG03:   13,14-dihydro-15-keto Prostaglandin F2α  (9α,11α) -Dihydroxy-15-oxo-prost-5(Z)-en-1-oic acid  
  43. LBF20115PG04:   13,14-dihydro Prostaglandin F2α  (9α,11α,15S) -Trihydroxy-prost-5(Z)-en-1-oic acid  
  44. LBF20115PG05:   8-iso-13,14-dihydro-15-keto Prostaglandin F2α  (9α,11α)-Dihydroxy-15-oxo- (8β) -prost-5(Z)-en-1-oic acid  
  45. LBF20118BC01:   2,4-Dimethyl-2-icosenoic acid  2,4-Dimethyleicosenoic acid  
  46. LBF20118BC02:   2-Methyl-2-eicosenoic acid  
  47. LBF20203PG01:   δ17-Prostaglandin E_1  9-Oxo- (11α,15S) -dihydroxy-prosta- (13E,17Z) -dien-1-oic acid
  48. LBF20203PG02:   δ17-6-keto Prostaglandin F_1α  6-Oxo- (9α,11α,15S) -trihydroxy-prosta- (13E,17Z) -dien-1-oic acid
  49. LBF20206HO01:   11R-Hydroxy- (12E,14Z) -eicosadienoic acid  
  50. LBF20206HO02:   11S-Hydroxy- (12E,14Z) -eicosadienoic acid  
  51. LBF20206HP01:   Methyl-6,8,9,11-bisepidioxy-5-hydroperoxy-12,14-eicosadienoic acid  
  52. LBF20206SC01:   11, 14-Eicosadienoic acid  
  53. LBF20207HO01:   15R-Hydroxy- (11Z,13E) -eicosadienoic acid  
  54. LBF20207HO02:   15S-Hydroxy- (11Z,13E) -eicosadienoic acid  
  55. LBF20207HP01:   15S-Hydroperoxy- (11Z,13E) -eicosadienoic acid  
  56. LBF20207HP02:   7- [3,5-Epidioxy-2- (3-hydroperoxy-1-octenyl) cycropentyl] -5-heptenoic acid  
  57. LBF20207OX01:   15-Oxo-(11Z,13E) -eicosadienoic acid  
  58. LBF20207PG01:   Prostaglandin A_1  (8R,12S,13E,15S) -15-Hydroxy-9-oxo-10,13-prostadienoic acid  7- [ 2 (R) - (3 (S) -Hydroxy-1 (E) -octenyl) -5-oxo-3-cyclopenten-1 (R) -yl ] heptanoic acid
  59. LBF20207PG02:   Prostaglandin B_1  (E,S) -15-Hydroxy-9-oxo-8 (12) ,13-prostadienoic acid  7- [ 2- (3S -Hydroxy-1(E)-octenyl) -5-oxo-3-cyclopenten-1 -yl ] heptanoic acid  
  60. LBF20207PG10:   15-epi Prostaglandin A_1  9-Oxo-15R-hydroxy-prostsa- (10Z,13E) -dien-1-oic acid  
  61. LBF20207PG22:   Prostaglandin D_2  7- [ 5 (S) -Hydroxy-2 (R) - (3 (S) -hydroxy-1 (E) -octenyl) -3-oxocyclopentan-1 (R) -yl ] -5 (Z) -heptenoic acid  
  62. LBF20207PG23:   Prostaglandin E_2  7- [ 3 (R) -Hydroxy-2 (R) - (3 (S) -hydroxy-1 (E) -octenyl-5-oxocyclopentan-1 (R) -yl ] -5 (Z) -heptenoic acid
  63. LBF20207PG24:   15-keto Prostaglandin E_2  7- [ 3 (R) -Hydroxy-2 (R) - (3-oxo-1 (E) -octenyl) -5-oxocyclopentan-1 (R) -yl ] -5 (Z) -heptenoic acid  
  64. LBF20207PG25:   Prostaglandin F2α  7- [ 3 (R) ,5 (S) -Dihydroxy-2 (R) - (3 (S) -hydroxy-1 (E) -octenyl) cyclopentan-1 (R) -yl ] -5 (Z) -heptenoic acid  
  65. LBF20207PG26:   15-keto Prostaglandin F2α  7- [ (3R,5S) -Dihydroxy-2R - (3-oxo-1(E)-octenyl)- cyclopentan-1R -yl ] -5-(Z)-heptenoic acid  
  66. LBF20207PG27:   Prostaglandin G_2  7- [ 2R- (3S -Hydroxy-1-(E)-octenyl) -(1R,4S) -5,6-dioxabicyclo [ 2.2.1 ] -heptan-3R-yl ] -5(Z)-heptenoic acid  
  67. LBF20207PG28:   5-trans Prostaglandin E_2  9-Oxo- (11α,15S) -dihydroxy-prosta- (5E,13E) -dien-1-oic acid  
  68. LBF20207PG29:   19(R) -hydroxy Prostaglandin E_2  9-Oxo- (11α,15S,19R) -trihydroxy-prosta- (5Z,13E) -dien-1-oic acid
  69. LBF20207PG30:   20-hydroxy Prostaglandin E_2  9-Oxo- (11α,15S,20) --trihydroxy-prosta- (5Z,13E) -dien-1-oic acid  
  70. LBF20207PG31:   11β- Prostaglandin F2α  (9α,11β,15S) -Trihydroxy-prosta- (5Z,13E) -dien-1-oic acid
  71. LBF20207PG32:   19(R) -hydroxy Prostaglandin F2α  (9α.11α,15S,19R) -Tetrahydroxy-prosta- (5Z,13E) -dien-1-oic acid  
  72. LBF20207PG33:   20-HydroxyProstaglandin F2α  (9α,11α,15S,20) -Tetrahydroxy-prosta- (5Z,13E) -dien-1-oic acid  
  73. LBF20207PG34:   11β- Prostaglandin E_2  9-Oxo- (11β,15S) -dihydroxy-prosta- (5Z,13E) -dien-1-oic acid  
  74. LBF20207PG35:   11-deoxy Prostaglandin E_2  9-Oxo-15S-hydroxy-prosta- (5Z,13E) -dien-1-oic acid  
  75. LBF20207PG36:   Prostaglandin F2α 1,11-lactone  (9α,11α,15S) -Trihydroxy-prosta- (5Z,13E) -dien-1-oic acid, 1,11-lactone  
  76. LBF20207PG37:   Prostaglandin F2α 1,15-lactone  (9α,11α,15S) -Trihydroxy-prosta- (5Z,13E) -dien-1-oic acid, 1,15-lactone  
  77. LBF20207PG38:   5-trans Prostaglandin F2α  (9α,11α,15S) -Trihydroxy-prosta- (5E,13E) -dien-1-oic acid  
  78. LBF20207PG39:   11-deoxy Prostaglandin F2α  (9α,15S) -Dihydroxy-prosta- (5Z,13E) -dien-1-oic acid  
  79. LBF20207PG40:   Prostaglandin F2β  (9β,11α,15S) -Trihydroxy-prosta- (5Z,13E) -dien-1-oic acid  
  80. LBF20207PG41:   15(R) - Prostaglandin D_2  (9S,15R) -Dihydroxy-11-oxo- (5Z,13E) -prostadienoic acid  (9α,15R) -Dihydroxy-11-oxo-prosta- (5Z,13E) -dien-1-oic acid  
  81. LBF20207PG42:   15(R) - Prostaglandin E_2  9-Oxo- (11α,15R) -dihydroxy-prosta- (5Z,13E) -dien-1-oic acid  
  82. LBF20207PG43:   8-iso Prostaglandin E_2  9-Oxo- (11α,15S) -dihydroxy- (8β) -prosta- (5Z,13E) -dien-1-oic acid  
  83. LBF20207PG44:   Prostaglandin F2α alcohol  (1,9α,11α,15S) -Tetrahydroxyprosta- (5Z,13E) -dien  
  84. LBF20207PG45:   15R- Prostaglandin F2α  (9α,11α,15R) -Trihydroxy-prosta- (5Z,13E) -dien-1-oic acid  
  85. LBF20207PG46:   8-iso Prostaglandin F2α  (9α,11α,15S) -Trihydroxy- (8β) -prosta- (5Z,13E) -dien-1-oic acid  
  86. LBF20207PG47:   8-iso-15-keto Prostaglandin F2α  (9α,11α) -Dihydroxy-15-oxo- (8β) -prosta- (5Z,13E) -dien-1-oic acid  
  87. LBF20207PG48:   8-iso Prostaglandin F2β  (9β,11α,15S) -Trihydroxy- (8β) -prosta- (5Z,13E) -dien-1-oic acid  
  88. LBF20207PG49:   Prostaglandin H_2  (9α,11α) -Epidioxy-15S-hydroxy-prosta- (5Z,13E) -dien-1-oic acid  
  89. LBF20207PG50:   15-epi Prostaglandin E2 acetate, methyl ester  (5Z, 13E) - (8R,11R,12R,15R) -11,15-Dihydroxy-9-oxoprost-5,13-dienoic acid  
  90. LBF20207PG51:   Prostaglandin I_2  5 (Z) - [ 7 (R) -Hydroxy-6 (R) - (3 (S) -hydroxyocten-1 (E) -yl) -1 (S) ,5 (R) -2-oxabicyclo [ 3.3.0 ] oct-3-ylidenpentanoic acid  
  91. LBF20207PG52:   15R - Prostaglandin F2α  (9α,11α,15R) -Trihydroxy-prosta- (5Z,13E) -dien-1-oic acid  
  92. LBF20207PG53:   15S-15-methyl Prostaglandin D_2  (9α,15S) -Dihydroxy-11-oxo-15-methylprosta- (5Z,13E) -dien-1-oic acid  
  93. LBF20207PG54:   9-deoxy-9-methylene Prostaglandin E_2  9-Methylene- (11α,15S) -dihydroxy-prosta- (5Z,13E) -dien-1-oic acid  
  94. LBF20207PG55:   15R-15-methyl Prostaglandin E_2  9-Oxo- (11α,15R) -dihydroxy-15-methyl-prosta- (5Z,13E) -dien-1-oic acid  
  95. LBF20207PG56:   15S-15-methyl Prostaglandin E_2  9-Oxo- (11α,15S) -dihydroxy-15-methyl-prosta- (5Z,13E) -dien-1-oic acid  
  96. LBF20207PG57:   Prostaglandin F2α alcohol methyl ether  1-Methyl- (9α,11α,15S) -trihydroxy-prosta- (5Z,13E) -diene
  97. LBF20207PG58:   15S-15-methyl Prostaglandin F2α  (9α,11α,15S) -Trihydroxy-15-methyl-prosta- (5Z,13E) -dien-1-oic acid  
  98. LBF20207PG59:   11-deoxy-11-methylene Prostaglandin D_2  (9α,15S) -Dihydroxy-11-methylene-prosta- (5Z,13E) -dien-1-oic acid  
  99. LBF20207PG60:   11-deoxy-11-methylene-15-keto Prostaglandin D_2  9α-Hydroxy-11-methylene-15-oxo-prosta- (5Z,13E) -dien-1-oic acid
  100. LBF20207PG61:   15R-15-methyl Prostaglandin D_2  (9α,15R) -Dihydroxy-11-oxo-15-methyl-prosta- (5Z,13E) -dien-1-oic acid
  101. LBF20207PG62:   Prostaglandin F2α methyl ester  (9α,11α,15S) -Trihydroxy-prosta- (5Z,13E) -dien-1-oic acid, methyl ester  
  102. LBF20207PG63:   15R-15-methyl Prostaglandin F2α  (9α,11α,15R) -Trihydroxy-15-methyl-prosta- (5Z,13E) -dien-1-oic acid  
  103. LBF20207PG64:   15-epi Prostaglandin E2 methyl ester  Methyl-(8R,11R,12R,15R) -11,15-dihydroxy-9-oxoprost- (5Z, 13E) -dienoic acid  
  104. LBF20207PG65:   16,16-dimethyl Prostaglandin D_2  (9α,15R) -Dihydroxy-11-oxo-16,16-dimethyl-prost- (5Z,13E) -dien-1-oic acid  
  105. LBF20207PG66:   11-deoxy-16,16-dimethyl Prostaglandin E_2  9-Oxo-15R-hydroxy-16,16-dimethyl-prost- (5Z,13E) -dien-1-oic acid
  106. LBF20207PG67:   16,16-dimethyl Prostaglandin E_2  9-Oxo- (11α,15R) -dihydroxy-16,16-dimethyl-prosta- (5Z,13E) -dien-1-oic acid  
  107. LBF20207PG68:   Prostaglandin F2α dimethylamide  N,N-Dimethyl- (9α,11α,15S) -trihydroxy-prosta- (5Z,13E) -dien-1-amide  
  108. LBF20207PG69:   Prostaglandin F2α ethanolamide  N- (2-Hydroxyethyl) - (9α,11α,15S) -trihydroxy-prosta- (5Z,13E) -dien-1-amide  
  109. LBF20207PG70:   16,16-dimethyl Prostaglandin F2β  (9β,11α,15R) -Trihydroxy-16,16-dimethyl-prosta-(5Z,13E) -dien-1-oic acid  
  110. LBF20207PG71:   Prostaglandin F2 α dimethyl amine  1-Dimethylamino-(9α,11α,15S) -trihydroxy-prosta- (5Z,13E) -diene
  111. LBF20207PG72:   15S-15-methyl Prostaglandin F2α methyl ester  (9α,11α,15S) -Trihydroxy-15-methyl-prosta- (5Z,13E) -dien-1-oic acid, methyl ester  
  112. LBF20207PG73:   Prostaglandin F2α-11-acetate  (8R,9S,11R,12R,15S) -11-Acetoxy-9,15-dihydroxyprost-(5Z,13E)-dienoic acid  
  113. LBF20207PG74:   9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E_2  9-Methylene-(11α,15R) -dihydroxy-16,16-dimethyl-prosta- (5Z,13E) -dien-1-oic acid  
  114. LBF20207PG75:   Prostaglandin F2α isopropyl ester  (9α,11α,15S) -Trihydroxy-prosta- (5Z,13E) -dien-1-oic acid, isopropyl ester  
  115. LBF20207PG76:   Prostaglandin F2α-11-acetate methyl ester  Methyl- (8R,9S,11R,12R,15S) -11-Acetoxy-9,15-dihydroxyprost- (5Z,13E) -dienoic acid  
  116. LBF20207PG77:   18-acetoxy Prostaglandin F2α-11-acetate  (8R,9S,11R,12R,15S) -11,18-Diacetoxy-9,15-dihydroxyprost- (5Z,13E) -dienoic acid  
  117. LBF20207PG78:   18-acetoxy Prostaglandin F2α-11-acetate methyl ester  Methyl- (8R,9S,11R,12R,15S) -11,18-diacetoxy-9,15-dihydroxyprost- (5Z,13E) -dienoic acid  
  118. LBF20207PG79:   16,16-dimethyl Prostaglandin A_1  9-Oxo-15R-hydroxy-16,16-dimethyl-prost- (10,13E) -dien-1-oic acid  
  119. LBF20207TX01:   Thromboxane A_2  7- [ 3- (3 (S) -Hydroxy-1 (E) -octenyl) -1 (S) ,5 (S) ,4,6-dioxabicyclo [ 3.1.1 ] hept-2-yl ] -5 (Z) -heptenoic acid  
  120. LBF20207TX02:   Thromboxane B2  7- [ Tetrahydro-4 (S) ,6-dihydroxy-2 (R) - (3 (S) -hydroxy-1 (E) -octenyl) -2H-pyran-3 (S) -yl ] -5 (Z) -heptenoic acid  
  121. LBF20207TX03:   11-dehydro Thromboxane B_2  7- [Tetrahydro-4 (S) -hydroxy-2 (R) - (3 (S) -hydroxy-1 (E) -octenyl) -6-oxo-2H-pyran-3 (S) -yl] -5 (Z) -heptenoic acid  
  122. LBF20208PG01:   δ12- Prostaglandin D_2  (9α,15S) -Dihydroxy-11-oxo-prosta- (5Z,12E) -dien-1-oic acid  
  123. LBF20210PG01:   113,14-dihydro-15-keto Prostaglandin A_2  9,15-Dioxo- (5Z,10) -prostadienoic acid  
  124. LBF20212LT01:   10,11,14,15-tetrahydro-12-keto-Leukotriene B4  5S-Hydroxy-12R-keto- (6Z,8E) -eicosatedienoic acid  
  125. LBF20303PG03:   Prostaglandin E_3  (5Z,8R,11R,12R,13E,15S,17Z) -11,15-Dihydroxy-9-oxo-5,13,17-prostatrienoic acid  7- [ 3 (R) -Hydroxy-2 (R) - (3 (S) -hydroxyocta-1 (E) ,5 (Z) -dienyl) -5-oxocyclopentan-1 (R) -yl ] -5 (Z) -heptenoic acid  
  126. LBF20303PG04:   Prostaglandin F3α  (5Z,8R,9S,11R,12R,13E,15S,17Z) -9,11,15-Trihydroxyprosta-5,13,17-trienoic acid  7- [ 3 (R) ,5 (S) -Dihydroxy-2 (R) - (3 (S) -hydroxyocta-1 (E) ,5 (Z) -dienyl) cyclopentan-1 (R) -yl ] -5 (Z) -heptenoic acid  
  127. LBF20303PG05:   Prostaglandin D_3  (9α,15S) -Dihydroxy-11-oxo-prosta- (5Z,13E,17Z) -trien-1-oic acid  
  128. LBF20303PG06:   Prostaglandin I_3  (6,9α) -Epoxy- (11α,15S) -dihydroxy-prosta- (5Z,13E,17Z) -trien-1-oic acid  
  129. LBF20303PG07:   8-iso Prostaglandin F3α  (9α,11α,15S) -Trihydroxy- (8b) -prosta- (5Z,13E,17Z) -trien-1-oic acid  
  130. LBF20303SC01:   11, 14, 17-Eicosatrienoic acid  
  131. LBF20303TX01:   Thromboxane A_3  7- [3- (3S -Hydroxy- (1E,5Z) -octadienyl) -(1S,5S,4,6) -dioxabicyclo [ 3.1.1 ] hept-2-yl] -5(Z) -heptenoic acid  
  132. LBF20303TX02:   Thromboxane B_3  7- [Tetrahydro- (4S,6) -dihydroxy-2R- (3S-hydroxy- (1E,5Z) -octadienyl) -2H-pyran-3S-yl] -5(Z) -heptenoic acid  
  133. LBF20306CV01:   Preclavulone lactone I  4R- {3Z- [ (1R,2S) -2- (2Z-Octenyl) -5-oxo-3-cyclopentenyl] -1-propenyl} -4-butanolide  
  134. LBF20306CV02:   Preclavulone lactone II  4R- {3E- [ (1R,2S) -2- (2Z-Octenyl) -5-oxo-3-cyclopentenyl] -1-propenyl}-4-butanolide  
  135. LBF20306CV03:   10,11-epoxy Chlorovulone I  Methyl- (5Z,7E) -7- [ (2S,3S,4R) -4-chloro-3,4-epoxy-2-hydroxy-2- (2Z-octenyl) -5-oxo-3-cyclopentanylidene] -5-heptenoic acid  
  136. LBF20306EO01:   (+-) -5 (6) -Epoxy- (8Z,11Z,14Z) -eicosatrienoic acid  
  137. LBF20306EO02:   (+-) -8 (9) -Epoxy- (5Z,11Z,14Z) -eicosatrienoic acid  
  138. LBF20306EO03:   (+-) -11 (12) -Epoxy- (5Z,8Z,14Z) -eicosatrienoic acid  11,12-EET  
  139. LBF20306HO01:   (+-) -5, 6-Dihydroxy- (8Z,11Z,14Z) -eicosatrienoic acid  
  140. LBF20306HO02:   (+-) -8,9-Dihydroxy- (5Z,11Z,14Z) -eicosatrienoic acid  
  141. LBF20306HO03:   (+-) -11,12-Dihydroxy- (5Z,8Z,14Z) -eicosatrienoic acid  
  142. LBF20306HO05:   8S-Hydroxy- (9E,11Z,14Z) -eicosatrienoic acid  
  143. LBF20306HO07:   (R) , (Z,Z,Z) -12-Hydroxy-5,8,14-eicosatrienoic acid  12R-Hydroxy- (5Z,8Z,14Z) -eicosatrienoic acid  
  144. LBF20306HX01:   Trioxilin A_3  (8,11R,12S) -Trihydroxy- (5Z,9E,14Z) -eicosatrienoic acid
  145. LBF20306HX02:   Trioxilin B_3  (10,11S,12R) -Trihydroxy- (5Z,8Z,14Z) -eicosatrienoic acid  
  146. LBF20306HX03:   Hepoxilin A_3  8-Hydroxy- (11S,12S)-epoxy- (5Z,9E,14Z) -eicosatrienoic acid  8-Hydroxy-11,12 (S,S) -epoxyeicosa-5,14 (Z,Z) ,9 (E) -trienoic acid  
  147. LBF20306HX04:   Hepoxilin B_3  10-Hydroxy- (11R,12S)-epoxy- (5Z,8Z,14Z) -eicosatrienoic acid  10-Hydroxy-11 (R) ,12 (S) -epoxyeicosa-5,8,14 (Z,Z,Z) -trienoic acid  
  148. LBF20306PG01:   15-deoxy-Δ12.14- Prostaglandin D_2  9α-Hydroxy-11-oxo-prosta- (5Z,12E,14E) -trien-1-oic acid  
  149. LBF20306SC01:   (8Z,11Z,14Z) -Eicosatrienoic acid  Bishomo-γ-linolenic acid  Dihomo-γ-linolenic acid  
  150. LBF20306SC02:   Podocarpric acid  
  151. LBF20307HO01:   15S-Hydroxy- (8Z,11Z,13E) -eicosatrienoic acid  
  152. LBF20307HP01:   Methyl-9,11-epidioxy-12,15-dihydroperoxy-5,7,13-eicosatrienoic acid  
  153. LBF20307HP02:   Methyl-6,8-epidioxy-5,15-dihydroperoxy-9,11,13-eicosatrienoic acid  
  154. LBF20307PG01:   Prostaglandin A_2  7- [2R- (3S-Hydroxy-1-(E)-octenyl) -5-oxo-3-cyclopenten-1R-yl] -5-(Z) -heptenoic acid  9-Oxo-15S-hydroxy- (5Z,10Z,13E) -prostatrienoic acid  
  155. LBF20307PG02:   19-hydroxy Prostaglandin A_2  (15S,19)-Dihydroxy-9-oxo-8(12),13-trans-prostadienoic acid  7- [2R- ((3S,7)-Dihydroxy-1-(E)-octenyl) -5-oxo-3-cyclopenten-1R-yl] -5-(Z)-heptenoic acid  9-Oxo- (15S,19) -dihydroxy- (5Z,10Z,13E) -prostatrienoic acid  
  156. LBF20307PG03:   Prostaglandin B_2  7- [2R- (3S-Hydroxy-1-(E)-octenyl) -5-oxo-1-cyclopenten-1R-yl] -5-(Z) -heptenoic acid  
  157. LBF20307PG04:   19-hydroxy Prostaglandin B_2  (15S,19)-Dihydroxy-9-oxo-5-cis-8(12),13-trans-prostadienoic acid  7- [2R- ((3S,7)-Dihydroxy-1-(E)-octenyl) -5-oxo-1-cyclopenten-1R-yl] -5-(Z)-heptenoic acid
  158. LBF20307PG05:   Prostaglandin C_2  7- [2R- (3S-Hydroxy-1-(E)-octenyl) -5-oxo-2-cyclopenten-1R-yl] -5-(Z)-heptenoic acid  
  159. LBF20307PG06:   16,16-dimethyl Prostaglandin A_2  9-Oxo-15R-hydroxy-16,16-dimethyl-prosta- (5Z,10,13E) -trien-1-oic acid  
  160. LBF20307PG38:   Prostaglandin J_2  7- [2R- (3S-Hydroxy-1-(E)-octenyl) -3-oxo-4-cyclopenten-1R-yl] -5-(Z)-heptenoic acid  
  161. LBF20307PG39:   15-epi Prostaglandin A_2  (5Z,13E)-(8R,12S,15R) -15-Hydroxy-9-oxoprost-5,10,13-trienoic acid  
  162. LBF20307PG41:   5-trans- Prostaglandin A_2  (5E,13E)-(8R,12S,15S)-15-Hydroxy-9-oxoprost-5,10,13-trienoic acid  
  163. LBF20308PG01:   Δ12- Prostaglandin J_2  (5Z,12E)-11-Oxo-15S-hydroxy-prosta-5,9,12-trien-1-oic acid  
  164. LBF20308PG03:   7- [2-(E)- (3S-Hydroxyoctylidene) -3-oxo-4-cyclopenten-1R-yl] -5-(Z) -heptenoic acid  
  165. LBF20309EO01:   (+-) -14 (15) -Epoxy- (5Z,8Z,11Z) -eicosatrienoic acid  
  166. LBF20309HO01:   (+-) -14,15-Dihydroxy-5Z,8Z,11Z-eicosatrienoic acid  dl-14,15-Dihydroxy- (5Z,8Z,11Z) -eicosatrienoic acid  
  167. LBF20309HO02:   (6E,8Z,11Z) -5S-Hydroxy-eicosatrienoic acid  
  168. LBF20309SC01:   5, 8, 11-Eicosatrienoic acid  
  169. LBF20402SC01:   6, 10, 14, 18-Eicosatetraenoic acid  
  170. LBF20403PG03:   Prostaglandin A_3  (5Z,13E,17Z)-15S-Hydroxy-9-oxo-prosta-5,10,13,17-tetraen-1-oic acid  
  171. LBF20403PG04:   Prostaglandin B_3  (5Z,13E,17Z)-15S-Hydroxy-9-oxo-prosta-5,8(12),13,17-tetraen-1-oic acid  
  172. LBF20403SC01:   8, 11, 14, 17-Eicosatetraenoic acid  
  173. LBF20404SC01:   4, 8, 12, 16-Eicosatetraenoic acid  
  174. LBF20406AM01:   N-Arachidonoylglycine  N- (5Z,8Z,11Z,14Z) -Eicosatetraenoyl-glycine  
  175. LBF20406AM02:   N-Arachidonoyl-D-serine  
  176. LBF20406AM03:   N-Arachidonoyl-L-serine  
  177. LBF20406AM04:   N-Ethylarachidonoylamide  N-Ethyl- (5Z,8Z,11Z,14Z) -eicosatetraenoylamine  
  178. LBF20406AM05:   N-Methylarachidonoylamide  N-Methyl- (5Z,8Z,11Z,14Z) -eicosatetraenoylamine  
  179. LBF20406AM06:   Arachidonoylamide  (5Z,8Z,11Z,14Z) -Eicosatetraenoylamine  
  180. LBF20406AM07:   N-Propylarachidonoylamide  N-Propyl- (5Z,8Z,11Z,14Z) -eicosatetraenoylamine  
  181. LBF20406AM08:   N-Isopropylarachidonoylamide  N-Isopropyl- (5Z,8Z,11Z,14Z) -eicosatetraenoylamine  
  182. LBF20406AM09:   N-Butylarachidonoylamide  N-Butyl- (5Z,8Z,11Z,14Z) -eicosatetraenoylamine  
  183. LBF20406AM10:   N-Tert-butylarachidonoylamide  N-Tert-butyl- (5Z,8Z,11Z,14Z) -eicosatetraenoylamine  
  184. LBF20406AM11:   N-Amylarachidohoylamide  N- (5Z,8Z,11Z,14Z) -Eicosatetraenoylamine  
  185. LBF20406AM12:   N- (3-Methylbutyl)arachidonoylamide  N- (3-Methylbutyl)- (5Z,8Z,11Z,14Z) -eicosatetraenoylamine  
  186. LBF20406AM13:   N- (1,1-Dimethylpropyl)arachidonoylamide  N- (1,1-Dimethylpropyl)- (5Z,8Z,11Z,14Z) -eicosatetraenoylamine  
  187. LBF20406AM14:   N- ( (R) - (-) -1-Methylpropyl)arachidonoylamide  N- ( (R) - (-) -1-Methylpropyl)- (5Z,8Z,11Z,14Z) -eicosatetraenoylamine  
  188. LBF20406AM15:   N- ( (S) - (+) -1-Methylpropyl)arachidonoylamide  N- ( (S) - (+) -1-Methylpropyl)- (5Z,8Z,11Z,14Z) -eicosatetraenoylamine  
  189. LBF20406AM16:   N- (3-Hydroxypropyl) -arachidonoylamide  N- (3-Hydroxypropyl) - (5Z,8Z,11Z,14Z) -eicosatetraenoylamine  
  190. LBF20406AM17:   N- (1,1-Dimethyl-2-hydroxyethyl) -arachidonoylamide  N- (1,1-Dimethyl-2-hydroxyethyl) - (5Z,8Z,11Z,14Z) -eicosatetraenoylamine  
  191. LBF20406AM18:   N- (5-Hydroxypentyl) -arachidonoylamide  N- (5-Hydroxypentyl)- (5Z,8Z,11Z,14Z) -eicosatetraenoylamine  
  192. LBF20406AM19:   N- (2-Methoxyethyl) -arachidonoylamide  N- (2-Methoxyethyl) - (5Z,8Z,11Z,14Z) -eicosatetraenoylamine  
  193. LBF20406AM20:   N'-Arachidonoyl-N"-diethylethylenediamine  N'- (5Z,8Z,11Z,14Z) -Eicosatetraenoyl-N"-diethylethylenediamine  
  194. LBF20406AM21:   N,N-Dimethylarachidonoylamide  N,N-Dimethyl- (5Z,8Z,11Z,14Z) -eicosatetraenoylamine  
  195. LBF20406AM22:   N,N-Diethylarachidonoylamide  N,N-Diethyl- (5Z,8Z,11Z,14Z) -eicosatetraenoylamine  
  196. LBF20406AM23:   N-Methyl-N- (2-hydroxyethyl) -arachidonoylamide  N-Methyl-N- (2-hydroxyethyl) - (5Z,8Z,11Z,14Z) -eicosatetraenoylamine  
  197. LBF20406AM24:   N-Ethyl-N- (2-hydroxyethyl) -arachidonoylamide  N-Ethyl-N- (2-hydroxyethyl) - (5Z,8Z,11Z,14Z) -eicosatetraenoylamine  
  198. LBF20406AM25:   N-Propyl-N- (2-hydroxyethyl) -arachidonoylamide  N-Propyl-N- (2-hydroxyethyl) - (5Z,8Z,11Z,14Z) -eicosatetraenoylamine  
  199. LBF20406AM26:   N,N- (2,2-Dihydroxyethyl) -arachidonoylamide  N,N- (2,2-Dihydroxyethyl) - (5Z,8Z,11Z,14Z) -eicosatetraenoylamine  
  200. LBF20406AM27:   N-Hydroxy-N-arachidonoylamide  N-Hydroxy-N- (5Z,8Z,11Z,14Z) -eicosatetraenoylamine  
  201. LBF20406AM28:   α-Methylanandamide  N-2-Methy- (5Z,8Z,11Z,14Z) -eicosatetraenoylethanolamine  
  202. LBF20406AM29:   α,α-Dimethylanandamide  N-2,2-Dimethy- (5Z,8Z,11Z,14Z) -eicosatetraenoylethanolamine  
  203. LBF20406AM30:   N-Propyl-α-methylarachidonoylamide  N-Propyl-α-methyl- (5Z,8Z,11Z,14Z) -eicosatetraenoylamine  
  204. LBF20406AM31:   N-Propyl-α,α-dimethylarachidonoylamide  N-Propyl-α,α-dimethyl- (5Z,8Z,11Z,14Z) -eicosatetraenoylamine  
  205. LBF20406AM32:   N-Isopropyl-α-methylarachidonoylamide  N-Isopropyl-α-methyl- (5Z,8Z,11Z,14Z) -eicosatetraenoylamine  
  206. LBF20406AM33:   N-Isopropyl-α,α-dimethylarachidonoylamide  N-Isopropyl-α,α-dimethyl- (5Z,8Z,11Z,14Z) -eicosatetraenoylamine  
  207. LBF20406AM34:   N- (S) - (+) -2-Hydroxypropyl-α,α-dimethylarachidonoylamide  N- (S) - (+) -2-Hydroxypropyl-α,α-dimethyl- (5Z,8Z,11Z,14Z) -eicosatetraenoylamine  
  208. LBF20406AM35:   N- (R) - (-) -1-Methyl-2-hydroxyethyl-α,α-dimethylarachidonoylamide  N- (R) - (-) -1-Methyl-2-hydroxyethyl-α,α-dimethyl- (5Z,8Z,11Z,14Z) -eicosatetraenoylamine  
  209. LBF20406AM36:   N- (S) - (+) -1-Methyl-2-hydroxyethyl-α,α-dimethylarachidonoylamide  N- (S) - (+) -1-Methyl-2-hydroxyethyl-α,α-dimethyl- (5Z,8Z,11Z,14Z) -eicosatetraenoylamine  
  210. LBF20406AM37:   N- (R) -1-Methyl-2-hydroxyethylarachidonoylamide  N- (R) -1-Methyl-2-hydroxyethyl- (5Z,8Z,11Z,14Z) -eicosatetraenoylamine  
  211. LBF20406AM38:   N- (S) -2-Methyl-2-hydroxyethylarachidonoylamide  N- (S) -2-Methyl-2-hydroxyethyl- (5Z,8Z,11Z,14Z) -eicosatetraenoylamine  
  212. LBF20406AM39:   N- (R) - (-) -2-Hydroxypropyl-N- (R) - (-) -2-Hydroxypropyl-α,α-dimethylachidonoylamide  N- (R) - (-) -2-Hydroxypropyl-α,α-dimethyl- (5Z,8Z,11Z,14Z) -eicosatetraenoylamine  
  213. LBF20406AM40:   N- 2-Fluoroethylarachidonoylamide  N- 2-Fluoroethyl- (5Z,8Z,11Z,14Z) -eicosatetraenoylamine  
  214. LBF20406AM41:   Arachidonoylmorpholine  N-Morpholine- (5Z,8Z,11Z,14Z) -eicosatetraenoylamine  
  215. LBF20406AM42:   N- (1-Methyl-2-hydroxy-2-phenylethyl) -arachidonoylamide  (+-) -N- (1-Methyl-2-hydroxy-2-phenylethyl) - (5Z,8Z,11Z,14Z) -eicosatetraenoylamine  
  216. LBF20406AM43:   N- (2-Phenoxyethyl) -arachidonoylamide  N- (2-Phenoxyethyl) - (5Z,8Z,11Z,14Z) -eicosatetraenoylamine  
  217. LBF20406AM44:   Arachidonoyl-N- (4-benzenesulfonamide) amide  N-(4-Benzenesulfonamide)- (5Z,8Z,11Z,14Z) -eicosatetraenoylamine  
  218. LBF20406AM45:   Arachidonoyl- (4'-bromobenzenesulfon) amide  N-(4-Bromo-benzenesulfon)- (5Z,8Z,11Z,14Z) -eicosatetraenoylamine  
  219. LBF20406AM46:   Arachidonoyl- (2'- (4-bezenesulfonamide) ethyl) amide  N-(2'-(4-Benzenesulfonamide)-ethyl)- (5Z,8Z,11Z,14Z) -eicosatetraenoylamine  
  220. LBF20406CV01:   Clavulolactone II  4R- { (1E,3E) -3- [2S-Acetoxy-2- (2Z-octenyl) -5-oxo-3-cyclopentenylidene] -1-propenyl} -4-butanolide  
  221. LBF20406CV02:   Clavulolactone III  4R- { (1E,3Z) -3- [2S-Acetoxy-2- (2Z-octenyl) -5-oxo-3-cyclopentenylidene] -1-propenyl} -4-butanolide  
  222. LBF20406CV03:   4-epi Clavulone II  Methyl-4R- (5E,7E) -4-acetoxy-7- [2R-acetoxy-2- (2Z-octenyl) -5-oxo-3-cyclopentenylidene] -5-heptenoate  
  223. LBF20406CV04:   4-epi Clavulone III  Methyl-4R- (5E,7Z) -4-acetoxy-7- [2R-acetoxy-2- (2Z-octenyl) -5-oxo-3-cyclopentenylidene] -5-heptenoate te  
  224. LBF20406CV05:   Clavulone I  Claviridenone-d  Methyl-4R- (5Z,7E) -4-acetoxy-7- [ 2S-acetoxy-2- (2Z-octenyl) -5-oxo-3-cyclopentenylidene] -5-heptenoic acid  
  225. LBF20406CV06:   Clavulone II  Claviridenone-c  Methyl-4R- (5E,7E) -4-acetoxy-7- [ 2S-acetoxy-2- (2Z-octenyl) -5-oxo-3-cyclopentenylidene] -5-heptenoic acid  
  226. LBF20406CV07:   Clavulone III  Claviridenone-b  Methyl-4R- (5E,7Z) -4-acetoxy-7- [ 2S-acetoxy-2- (2Z-octenyl) -5-oxo-3-cyclopentenylidene] -5-heptenoic acid  
  227. LBF20406CV08:   Clavulone IV  Claviridenone-a  Methyl-4R- (5Z,7Z) -4-acetoxy-7- [ 2S-acetoxy-2- (2Z-octenyl) -5-oxo-3-cyclopentenylidene] -5-heptenoic acid  
  228. LBF20406CV09:   20-Acetoxyclavulone I  Methyl-4R- (5Z,7E) -4-acetoxy-7- [ 2S-acetoxy-2- (7Z-acetoxy-2-octenyl) -5-oxo-3-cyclopentenylidene ] -5-heptenoic acid  
  229. LBF20406CV10:   20-Acetoxyclavulone II  Methyl-4R- (5E,7E) -4-acetoxy-7- [ 2S-acetoxy-2- (7Z-acetoxy-2-octenyl) -5-oxo-3-cyclopentenylidene ] -5-heptenoic acid
  230. LBF20406CV11:   20-Acetoxyclavulone III  Methyl-4R- (5E,7Z) -4-acetoxy-7- [ 2S-acetoxy-2- (7Z-acetoxy-2-octenyl) -5-oxo-3-cyclopentenylidene ] -5-heptenoic acid  
  231. LBF20406CV12:   Chlorovulone I  Methyl- (5Z,7E) -7- [4R-chloro-2-hydroxy-2- [(2Z-octenyl) -5-oxo-3-cyclopentenylidene] -5-heptenoic acid  
  232. LBF20406CV13:   Chlorovulone II  Methyl- (5E,7E) -7- [ 4R-chloro-2-hydroxy-2- [(2Z-octenyl) -5-oxo-3-cyclopentenylidene ] -5-heptenoic acid  
  233. LBF20406CV14:   Chlorovulone III  Methyl- (5E,7Z) -7- [ 4R-chloro-2-hydroxy-2- [(2Z-octenyl) -5-oxo-3-cyclopentenylidene ] -5-heptenoic acid  
  234. LBF20406CV15:   Chlorovulone IV  Methyl- (5Z,7Z) -7- [ 4R-chloro-2-hydroxy-2- [(2Z-octenyl) -5-oxo-3-cyclopentenylidene ] -5-heptenoic acid  
  235. LBF20406CV16:   Bromovulone I  Methyl- (5Z,7E) -7- [ 4R-bromo-2- [ (2Z-octenyl) -5-oxo-3-cyclopentenylidene ] -5-heptenoic acid  
  236. LBF20406CV17:   Iodovulone I  Methyl- (5Z,7E) -7- [ 4R-4-iodoo-2-hydroxy-2- (2Z-octenyl) -5-oxo-3-cyclopentenylidene ] -5-heptenoic acid  
  237. LBF20406CV18:   Clavulolactone I  4R-{ (1Z,3E) -3-[ 2S-Acetoxy-2- [ (2Z-octenyl) -5-oxo-3-cyclopentenylidene ] -1-propenyl}-4-butanolide  
  238. LBF20406EO01:   (17R,18S) -Epoxy- (5Z,8Z,11Z,14Z) -eicosatetraenoic acid  
  239. LBF20406HO07:   (5S,6R) -Dihydroxy- (7E,9E,11Z,14Z) -eicosatetraenoic acid  
  240. LBF20406HO08:   (5S,6S) -Dihydroxy- (7E,9E,11Z,14Z) -eicosatetraenoic acid  
  241. LBF20406HO09:   3R-Hydroxy- (5Z,8Z,11Z,14Z) -eicosatetraenoic acid  
  242. LBF20406HO10:   5R-Hydroxy- (6E,8Z,11Z,14Z) -eicosatetraenoic acid  
  243. LBF20406HO11:   5S-Hydroxy- (6E,8Z,11Z,14Z) -eicosatetraenoic acid  5-HETE  
  244. LBF20406HO12:   8R-Hydroxy- (5Z,9E,11Z,14Z) -eicosatetraenoic acid  
  245. LBF20406HO13:   8S-Hydroxy- (5Z,9E,11Z,14Z) -eicosatetraenoic acid  
  246. LBF20406HO14:   9R-Hydroxy- (5Z,7E,11Z,14Z) -eicosatetraenoic acid  
  247. LBF20406HO15:   9S-Hydroxy- (5Z,7E,11Z,14Z) -eicosatetraenoic acid  
  248. LBF20406HO16:   11R-Hydroxy- (5Z,8Z,12E,14Z) -eicosatetraenoic acid  
  249. LBF20406HO17:   11S-Hydroxy- (5Z,8Z,12E,14Z) -eicosatetraenoic acid  
  250. LBF20406HO18:   12R-Hydroxy- (5Z,8Z,10E,14Z) -eicosatetraenoic acid  
  251. LBF20406HO19:   20-Hydroxy- (5Z,8Z,11Z,14Z) -eicosatetraenoic acid  
  252. LBF20406HO20:   5S-Hydroxy- (6E,8Z,11Z,14Z) -eicosatetraenoic acid  5-HETE  
  253. LBF20406HO21:   12S-Hydroxy- (5Z,8E,10Z,14Z) -eicosatetraenoic acid  
  254. LBF20406HO22:   8R-Hydroxy- (5Z,9E,11Z,14Z) -eicosatetraenoic acid  (R) , (Z,E,Z,Z) -8-Hydroxy-5,9,11,14-eicosatetraenoic acid  
  255. LBF20406HO23:   12-Hydroxy- (5Z,8Z,10E,14Z) -eicosatetraenoic acid  12-HETE  
  256. LBF20406HP01:   5-Hydroperoxy- 6,8,11,14 -eicosatetraenoic acid  
  257. LBF20406HP02:   8-Hydroperoxy- 5,9,11,14 -eicosatetraenoic acid  
  258. LBF20406HP03:   9-Hydroperoxy- 5,7,11,14 -eicosatetraenoic acid  
  259. LBF20406HP04:   12-Hydroperoxy- (5Z,8,10E,14Z) -eicosatetraenoic acid  12-Hydroperoxy-5,8,10,14-Eicosatetraenoic Acid  
  260. LBF20406HP05:   15-Hydroperoxy- (5Z,8Z,11,13E) -eicosatetraenoic acid  15-Hydroperoxy-5,8,11,13-eicosatetraenoic acid  
  261. LBF20406HP06:   6-Hydroperoxy- (4E,8Z,11Z,14Z) -eicosatetraenoic acid  6-Hydroperoxy-4,8,11,14-eicosatetraenoic acid  
  262. LBF20406HP07:   14-Hydroperoxy- (5Z,8Z,11Z,15E) -eicosatetraenoic acid  14-Hydroperoxy-5,8,11,15-eicosatetraenoic acid  
  263. LBF20406HP08:   5,12-Dihydroperoxy-6,8,10,14-eicosatetraenoic acid  
  264. LBF20406HP09:   8,15-Dihydroperoxy-5,9,11,13-eicosatetraenoic acid  
  265. LBF20406HP10:   11-Hydroperoxy- 5,8,12,14 -eicosatetraenoic acid  
  266. LBF20406LT01:   Leukotriene A_4  (5S,6S) -Epoxy- (7E,9E,11Z,14Z) -tetraenoic acid  5 (S) ,6 (S) -Epoxyeicosa-7 (E) ,9 (E) ,11 (Z) ,14 (Z) -eicosatetraenoic acid  
  267. LBF20406LT02:   Leukotriene B_4  (5S,12R) -Dihydroxy- (6Z,8E,10E,14Z) -eicosatraenoic acid  5 (S) ,12 (R) -Dihydroxyeicosa-6 (Z) ,8 (E) ,10 (E) ,14 (Z) -tetraenoic acid  
  268. LBF20406LT03:   12-oxo-Leukotriene B_4  5S-12-Keto- (6Z,8E,10E,14Z) -eicosatraenoic acid  
  269. LBF20406LT04:   Leukotriene B4dimethylamide  N,N-Dimethyl- (5S,12R) -dihydroxy- (6Z,8E,10E,14Z) -eicosatetraenamide  
  270. LBF20406LT05:   Leukotriene B4ethanolamide  N- (2-Hydroxyethyl) - (5S,12R) -dihydroxy- (6Z,8E,10E,14Z) -eicosatetraenamide  
  271. LBF20406LT06:   6-trans Leukotriene B_4  (5S,12R) -Dihydroxy- (6E,8E,10E,14Z) -eicosatetraenoic acid  
  272. LBF20406LT07:   6-trans-12-epi Leukotriene B_4  (5S,12S) -Dihydroxy- (6E,8E,10E,14Z) -eicosatetraenoic acid
  273. LBF20406LT08:   12-epi Leukotriene B_4  (5S,12S) -Dihydroxy- (6Z,8E,10E,14Z) -eicosatetraenoic acid  
  274. LBF20406LT09:   20-carboxy Leukotriene B_4  (5S,12R) -Dihydroxy- (6Z,8E,10E,14Z) -eicosatetraenoic acid
  275. LBF20406LT10:   14,15-dehydro Leukotriene B_4  (5S,12R) -Dihydroxy- (6Z,8E,10E) -eicosatriene-14-ynoic acid  
  276. LBF20406LT11:   20-hydroxy Leukotriene B_4  (5S,12R,20) -Trihydroxy- (6Z,8E,10E,14Z) -eicosatetraenoic acid  20-hydroxy LTB4  
  277. LBF20406LT12:   20-trifluoro Leukotriene B_4  (5S,12R) -Dihydroxy-20,20,20-trifluoro- (6Z,8E,10E,14Z) -eicosatetraenoic acid  
  278. LBF20406LT13:   Leukotriene D_4  5S-Hydroxy-6R-S-cysteinylglycinyl- (7E,9E,11Z,14Z) -eicosatetraenoic acid  5 (S) -Hydroxy-6 (R) -S-cysteinylglycinyleicosa-7 (E) ,9 (E) ,11 (Z) ,14 (Z) -tetraenoic acid  
  279. LBF20406LT14:   Leukotriene C_4  5S-Hydroxy-6R-S-γ-glutamylcysteinylglycinyl- (7E,9E,11Z,14Z) -eicosatetraenoic acid  5 (S) -Hydoxy-6 (R) -S-γ-glutamylcysteinylglycinyleicosa-7 (E) ,9 (E) ,11 (Z) ,14 (Z) -tetraenoic acid  
  280. LBF20406LT15:   11-trans Leukotriene C_4  5S-Hydroxy-6R-S-glutathionyl- (7E,9E,11E,14Z) -eicosatetraenoic acid  
  281. LBF20406LT16:   11-trans Leukotriene D_4  5S-Hydroxy-6R-S-cysteinylglycinyl- (7E,9E,11E,14Z) -eicosatetraenoic acid  
  282. LBF20406LT17:   Leukotriene E_4  5S-Hydroxy-6R-S-cysteinyl- (7E,9E,11Z,14Z) -eicosatetraenoic acid  
  283. LBF20406LT18:   11-trans Leukotriene E_4  5S-Hydroxy-6R-S-cysteinyl- (7E,9E,11E,14Z) -eicosatetraenoic acid  
  284. LBF20406LT19:   N-acetyl Leukotriene E_4  5S-Hydroxy-6R-S-N-acetylcysteinyl-(7E,9E,11Z,14Z) -eicosatetraenoic acid  5 (S) -Hydroxy-6 (R) -S- (N-acetylcysteinyl) eicosa-7 (E) ,9 (E) ,11 (Z) ,14 (Z) -tetraenoic acid  
  285. LBF20406LT20:   Leukotriene F_4  5S-Hydroxy-6R-S-glutamylcysteinyl- (7E,9E,11Z,14Z) -eicosatetraenoic acid  5 (S) -Hydroxy-6 (R) -S-glutamylcysteinyleicosa-7 (E) ,9 (E) ,11 (Z) ,14 (Z) -tetraenoic acid  
  286. LBF20406OX01:   5-Oxo- (6E,8Z,11Z,14Z) -eicosatetraenoic acid  
  287. LBF20406OX02:   12-Oxo- (5Z,8Z,10E,14Z) -eicosatetraenoic acid  
  288. LBF20406PG02:   15-deoxy-Δ12.14- Prostaglandin J_2  11-Oxo-prosta- (5Z,9,12E,14Z) -tetraen-1-oic acid  
  289. LBF20406PH01:   Anandamide 0-phosphate  N- (5Z,8Z,11Z,14Z) -Tetraenoyleicosaethanolamine-O-phosphate  
  290. LBF20406SC01:   Arachidonic acid  (5Z,8Z,11Z,14Z) -Eicosatetraenoic acid  
  291. LBF20407HO02:   (5S,15S) -Dihydroxy- (6E,8Z,10Z,13E) -eicosatetraenoic acid  
  292. LBF20407HO04:   (8S,15S) -Dihydroxy- (5Z,9E,11Z,13E) -eicosatetraenoic acid  8,15-DiHETE  
  293. LBF20407HO05:   15R-Hydroxy- (5Z,8Z,10E,14Z) -eicosatetraenoic acid  
  294. LBF20407HO06:   15S-Hydroxy- (5Z,8Z,11Z,13E) -eicosatetraenoic acid  15-HETE  
  295. LBF20407HO07:   15S-Hydroxy- (5Z,8Z,11Z,13E) -eicosatetraenoic acid  15(S) -Hydroxy-5,8,11,13- (Z,Z,Z,E) -eicosatetraenoic acid  
  296. LBF20407HP01:   5,15-Dihydroperoxy-6,8,11,13-eicosatetraenoic acid  
  297. LBF20407LX01:   Lipoxin A_4  (5S,6R,15S) -Trihydroxy- (7E,9E,11Z,13E) -eicosatetraenoic acid  
  298. LBF20407OX01:   15-Oxo- (5Z,8Z,11Z,13E) -eicosatetraenoic acid  
  299. LBF20408LX01:   Lipoxin B_4  (5S,14R,15S) -Trihydroxy- (6E,8Z,10E,12E) - eicosatetraenoic acid
  300. LBF20502SC01:   Timnodonic acid  
  301. LBF20503HO01:   8R-Hydroxy- (5Z,9E,11Z,14Z,17Z) -eicosapentaenoic acid  
  302. LBF20503HO02:   8S-Hydroxy- (5Z,9E,11Z,14Z,17Z) -eicosapentaenoic acid  8-HEPE  
  303. LBF20503HO03:   9S-Hydroxy- (5Z,7E,11Z,14Z,17Z) -eicosapentaenoic acid  
  304. LBF20503HO04:   11R-Hydroxy- (5Z,8Z,12E,14Z,17Z) -eicosapentaenoic acid  
  305. LBF20503HO05:   11S-Hydroxy- (5Z,8Z,12E,14Z,17Z) -eicosapentaenoic acid  
  306. LBF20503HO06:   12R-Hydroxy- (5Z,8Z,10E,14Z,17Z) -eicosapentaenoic acid  
  307. LBF20503HO07:   12S-Hydroxy- (5Z,8Z,10E,14Z,17Z) -eicosapentaenoic acid  12-HEPE  
  308. LBF20503HO08:   15S-Hydroxy- (5Z,8Z,11Z,13E,17Z) -eicosapentaenoic acid  15-HEPE  
  309. LBF20503HO09:   5S-Hydroxy- (6E,8Z,11Z,14Z,17Z) -eicosapentaenoic acid  5-HEPE  
  310. LBF20503HP01:   5-Hydroperoxy-6,8,11,14,17-eicosapentaenoic acid  
  311. LBF20503HP02:   12S-Hydroperoxy- (5Z,8Z,10E,14Z,17Z) -eicosapentaenoic acid  
  312. LBF20503HP03:   15S-Hydroperoxy- (5Z,8Z,11Z,13E,17Z) -eicosadienoic acid  
  313. LBF20503HP04:   Methyl-6-hydroperoxy-4,8,11,14,17-eicosapentaenoic acid  
  314. LBF20503HP05:   Methyl-8-hydroperoxy-5,9,11,14,17-eicosapentaenic acid  
  315. LBF20503HP06:   Methyl-9-hydroperoxy-5,7,11,14,17-eicosapentaenoic acid  
  316. LBF20503HP07:   Methyl-11-hydroperoxy-5,8,12,14,17-eicosapentaenoic acid  
  317. LBF20503HP08:   5S-Hydroperoxy- (6E,8Z,11Z,14Z,17Z) -eicosadienoic acid  
  318. LBF20503LT01:   Leukotriene B_5  (5S,12R) -Dihydroxy- (6Z,8E,10E,14Z,17Z) -eicosapentaenoic acid  
  319. LBF20503SC01:   EPA  5, 8, 11, 14, 17-Eicosapentaenoic acid  
  320. LBF20504HO01:   (+-) -18-Hydroxy- (5Z,8Z,11Z,14Z,16E) -eicosapentaenoic acid  
Retrieved from "http://lipidbank.jp/mediawiki/index.php?title=Volatile:ListMol&oldid=117018"